Formulation Development

PPD's formulation development team enables us to leverage our cGMP lab's world-class inhalation testing capabilities. The team works in conjunction with material characterization, synthesis, extractables/leachables and inhalation testing to provide full support during the formulation development process.

PPD provides formulation development for the following dosage forms:

• Pressurized metered dose inhalers (pMDI) — solutions or suspensions
• Dry powder inhalers (DPI) — assive or active systems
• Nasal solution or suspension inhalers
• Nebulized solutions or suspensions

Formulation Development Services available include:

• Preformulation
• API characterization
• Formulation development and optimization
• Container/closure characterization and selection
• Method development and validation
• Process development and scale-up support
• Stability studies
• Product complaint analysis and testing